CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
批准号:
6170194
负责人:
MICHAEL T BERTON
金额:
$10.96万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2002-06-30
关键词:
B lymphocyte CD40 molecule DNA binding protein DNA footprinting RNase protection assay biological signal transduction gel mobility shift assay gene rearrangement gene targeting genetic mapping genetic regulatory element genetic transcription helper T lymphocyte immunoglobulin genes interleukin 4 interleukin 5 ligands nuclear runoff assay polymerase chain reaction site directed mutagenesis transfection
中文摘要
描述(改编自《调查者摘要》):长期目标
这一建议的目的是阐明辅助T(Th)的机制
小鼠同型转换的细胞调控和靶向性研究
B细胞。IL-4等细胞因子被认为是开关重组的靶点
通过诱导生殖系Ig基因转录,可能与特定的同型有关
使开关区域可被假定的开关重组酶访问。
提供了同种类型切换所需的T-cell触点相关信号
通过CD40配体(CD40L)-CD40的相互作用,但对其如何作用尚不清楚
这些信号调节同型转换。调查表明,
重组CD40L诱导生殖系γ-1和epsilon Ig的表达
基因以IL-4非依赖的方式,以及IL-4和CD40L协同作用
促进生殖系转录本的最大表达。这些结果和结果
来自其他实验室的研究表明,通过CD40L-CD40传递的信号
相互作用可以至少部分地在水平上调节同型转换
生殖系Ig基因转录。这项提议的中心目标是
详细描述CD40介导的调控机制
对生殖系γ-1免疫球蛋白基因转录的影响及确定作用
CD40介导的信号在激活γ-1开关区的作用
体内重组。一种基于聚合酶链式反应的分析方法将被用于测量开关
重组SGamma-1并确定CD40L和细胞因子是否以及何时
是激活DNA重组事件所必需的。的影响
CD40介导的信号对生殖系伽马-1转录表达的影响
以RNAase保护、核连续转录为详细特征
检测和信使核糖核酸稳定性研究。CD40反应元件,顺式作用元件
将通过瞬时转染生殖系伽马-1进行鉴定和定位
启动子-荧光素酶报告基因构建。CD40反应的DNA结合
负责调节生殖系γ-1Ig基因的蛋白质
转录将由EMSA鉴定,结合位点将由
DNA足迹和功能通过定点突变和
生殖系γ-1启动子-报告基因的转染构建。小说
DNA结合蛋白将通过生物化学和/或cdna克隆来分离。
并对其进行了详细的表征。最后,CD40应答在体内的作用
生殖系γ-1启动子结合蛋白在调节内源性生殖系中的作用
伽马-1转录和开关重组到SGamma-1将是
使用蛋白质和基因敲除策略的组合来确定。
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): The long-term objective
of this proposal is to elucidate the mechanisms underlying helper T (Th)
cell-mediated regulation and targeting of isotype switching in murine
B-cells. Cytokines such as IL-4 are believed to target switch recombination
to specific isotypes by inducing germline Ig gene transcription, possibly
making the switch regions accessible to a putative switch recombinase.
T-cell contact-dependent signals required for isotype switching are provided
by the CD40 ligand (CD40L)-CD40 interaction, but nothing is known about how
these signals regulate isotype switching. The investigation has shown that
recombinant CD40L induces expression of the germline gamma-1 and epsilon Ig
genes in an IL-4 independent manner, and that IL-4 and CD40L synergize to
promote maximal germline transcript expression. These results and results
from other laboratories suggest that signals delivered via the CD40L-CD40
interaction may regulate isotype switching, at least in part, at the level
of germline Ig gene transcription. The central goals of this proposal are
to characterize in detail the mechanisms underlying CD40-mediated regulation
of germline gamma-1 Ig gene transcription and to determine the role of
CD40-mediated signals in activating the gamma-1 switch region for
recombination in vivo. A PCR-based assay will be used to measure switch
recombination of Sgamma-1 and to determine if and when CD40L and cytokines
are required for activating the DNA recombination event. The effects of
CD40-mediated signals on germline gamma-1 transcript expression will be
characterized in detail by RNAase protection, nuclear run-on transcription
assays and mRNA stability studies. CD40-responsive, cis-acting elements
will be identified and mapped by transient transfection of germline gamma-1
promoter-luciferase reporter gene constructs. CD40-responsive DNA-binding
proteins responsible for regulation of germline gamma-1 Ig gene
transcription will be identified by EMSA, binding sites will be defined by
DNA footprinting, and function assessed by site-specific mutagenesis and
transfection of germline gamma-1 promoter-reporter gene constructs. Novel
DNA-binding proteins will be isolated biochemically and/or by cDNA cloning
and characterized in detail. Finally, the in vivo role of CD40-responsive
germline gamma-1 promoter-binding proteins in regulating endogenous germline
gamma-1 transcription and switch recombination to Sgamma-1 will be
determined using a combination of protein and gene knock-out strategies.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Regulation of the germline immunoglobulin Cgamma1 promoter by CD40 ligand and IL-4: dual role for tandem NF-kappaB binding sites.
CD40 配体和 IL-4 对种系免疫球蛋白 Cgamma1 启动子的调节:串联 NF-κB 结合位点的双重作用。
DOI:
10.1016/s0161-5890(98)00114-x
发表时间:
1999
期刊:
Molecular immunology
影响因子:
3.6
作者:
[Warren,WD, Roberts,KL, Linehan,LA, Berton,MT]
通讯作者:
Berton,MT
NF-kappaB elements associated with the Stat6 site in the germline gamma1 immunoglobulin promoter are not necessary for the transcriptional response to CD40 ligand.
与种系 gamma1 免疫球蛋白启动子中 Stat6 位点相关的 NF-kappaB 元件对于 CD40 配体的转录反应不是必需的。
DOI:
10.1093/intimm/dxh175
发表时间:
2004
期刊:
International immunology.
影响因子:
--
作者:
[Berton,MichaelT, Linehan,LeslieA, Wick,KerilynR, Dunnick,WesleyA]
通讯作者:
Dunnick,WesleyA
FACSAria Fusion cell sorter for Flow Cytometry Shared Resource
-
批准号:10431534
-
项目类别:
-
资助金额:$59.6万
-
财政年份:2022
-
负责人:MICHAEL T BERTON
-
依托单位:
A novel role for the TLR signaling adaptor TRAM
-
批准号:8304012
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2012
-
负责人:MICHAEL T BERTON
-
依托单位:
A novel role for the TLR signaling adaptor TRAM
-
批准号:8535602
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2012
-
负责人:MICHAEL T BERTON
-
依托单位:
Toll-Like Receptors and Immunity to F. tularensis
-
批准号:6912411
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2005
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6821998
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6685175
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:7006994
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6576428
-
项目类别:
-
资助金额:$31.77万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Fluorescence, Chemiluminescence and Phosphor Imager
-
批准号:6440395
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:7146699
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10237954
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10025088
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10460434
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10653911
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2072511
-
项目类别:
-
资助金额:$9.37万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2886930
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2672358
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2442606
-
项目类别:
-
资助金额:$9.74万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
MECHANISM OF ISOTYPE SWITCHING IN MURINE B LYMPHOCYTES
-
批准号:3029956
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1989
-
负责人:MICHAEL T BERTON
-
依托单位:
MECHANISM OF ISOTYPE SWITCHING IN MURINE B LYMPHOCYTES
-
批准号:3029957
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1989
-
负责人:MICHAEL T BERTON
-
依托单位: